Pseudomonas bacteria are widespread pathogens that account for considerable infections with significant morbidity and mortality, especially in hospitalized patients. The Pseudomonas genus contains a large number of species; however, the majority of infections are caused by Pseudomonas aeruginosa, infections by other Pseudomonas species are less reported. Pseudomonas stutzeri is a ubiquitous Gram-negative bacterium that has been reported as a causative agent of some infections, particularly in immunocompromised patients but has rarely been reported as a cause of infective endocarditis. Here, we report a case of a 55-year-old female with no significant medical history who presented with exertional dyspnea, productive cough, and fever. She was diagnosed as a case of acute anterior ST myocardial infarction, underwent double valve replacement surgery, and was found to have infective endocarditis caused by Pseudomonas stutzeri.
Purpose: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive development of kidney cysts and enlargement and dysfunction of the kidneys. The Consortium of Radiologic Imaging Studies of the Polycystic Kidney Disease (CRISP) cohort revealed that 89.1% had either a PKD1 or PKD2 mutation. Of the CRISP patients with a genetic cause detected, mutations in PKD1 accounted for 85%, while mutations in the PKD2 accounted for the remaining 15%. Here, we report exome sequencing of 16 Saudi patients diagnosed with ADPKD and 16 ethnically matched controls. Methods: Exome sequencing was performed using combinatorial probe-anchor synthesis and improved DNA Nanoballs technology on BGISEQ-500 sequencers (BGI, China) using the BGI Exome V4 (59 Mb) Kit. Identified variants were validated with Sanger sequencing. Results: With the exception of GC-rich exon 1, we obtained excellent coverage of PKD1 (mean read depth ¼ 88) including both duplicated and non-duplicated regions. Of nine patients with typical ADPKD presentations (bilateral symmetrical kidney involvement, positive family history, concordant imaging, and kidney function), four had protein truncating PKD1 mutations, one had a PKD1 missense mutation, and one had a PKD2 mutation. These variants have not been previously observed in the Saudi population. In seven clinically diagnosed ADPKD cases but with atypical features, no PKD1 or PKD2 mutations were identified, but rare predicted pathogenic heterozygous variants were found in cystogenic candidate genes including PKHD1, PKD1L3, EGF, CFTR, and TSC2. Conclusions: Mutations in PKD1 and PKD2 are the most common cause of ADPKD in Saudi patients with typical ADPKD.
Purpose: Multiple studies worldwide have reported the clinical and epidemiological features of coronavirus disease 2019 , with limited reports from the Middle East. This study describes the clinical and epidemiological features of COVID-19 cases in the Eastern Province of Saudi Arabia and identified factors associated with the severity of illness. Patients and Methods: This was an observational study of 341 COVID-19 cases. These cases were reported in the first three months after the first case in the country was identified. Clinical and demographic data were analyzed and described to identify the effects of age, sex, and ethnicity on illness severity. In addition, the duration of viral shedding and cycle threshold (Ct) values of real-time PCR were evaluated as predictors of severity. Results: The median age was 45 years. Males were twice as likely to be infected than females (p <0.0001). The duration of viral shedding ranged from 9 to 36 days. The most common clinical presentations include fever, shortness of breath, cough, myalgia, sore throat, vomiting, and headache. Critical cases were significantly higher in men (23% vs 8.7%), senior adults (>65 years), individuals of Bengali ethnicity, and in patients with comorbidities including diabetes, hypertension, and dyslipidemia (p =0.001). The case fatality rate was found to be 10%. The fatality was significantly higher in males than females (13.8% vs 2.6%), and in Asians (17.9%) than Arabs (6%) and Africans (0) (p =0.002). No association was found between viral load, represented by the RT-PCR cycle threshold (Ct) values, and severity of illness. Conclusion: Age, sex, and ethnicity are important predictors of COVID-19 severity. The cycle threshold (Ct) of the SARS-CoV-2 RT-PCR test cannot be used as a predictor of the criticality of illness.
Cardiac aspergillosis is a rare fungal infection that affects the heart and/or pericardium of immunocompromised patients. Here, the authors report a rare case of a 36-year-old female with aspergillus pericarditis. The patient was diagnosed with infective endocarditis and splenic infarction and treated with emergency splenectomy and double-valve replacement surgery. During the surgery, a fibropurulent pericardial tissue was found and excised. The culture report of the tissue confirmed the diagnosis of aspergillus pericarditis. The patient was successfully managed with intravenous voriconazole. Aspergillus do not usually infect the pericardium and such infections are rarely detected premortem, especially during a cardiac surgery. In this report, the infection was accidentally detected during the double-valve surgery. The authors conclude that because of its nonspecific clinical manifestations, a high degree of clinical suspicion is required for the early diagnosis and treatment of aspergillus pericarditis.
Myxomas originating from the aortic valve are rare. We report a 40-year-old male patient who presented to the King Fahd Hospital of the University, Khobar, Saudi Arabia, in 2017 with a stroke. Transoesophageal echocardiography indicated a mobile mass measuring 6 × 2 mm attached to the right coronary cusp of the aortic valve and a mobile interatrial septum with a small patent foramen ovale (PFO). The patient underwent surgical excision of the mass and direct closure of the PFO. Histopathology confirmed the mass to be a myxoma. Despite their rarity, the recognition and treatment of valvular myxomas is very important; moreover, clinicians should be aware that affected patients may present with an embolic stroke.Keywords: Aortic Valve; Myxoma; Patent Foramen Ovale; Stroke; Transesophageal Echocardiography; Case Report; Saudi Arabia.
Background Coagulation disorders are frequently encountered among coronavirus disease 2019 [COVID-19]-infected patients, especially among those with more severe symptoms. This study aims to determine the incidence and risk factors of venous thromboembolism [VTE] in COVID-19 patients.Methods The retrospective observational Cohort study was conducted from March to July 2020. All adult patients [>18 years old] with laboratory-confirmed COVID-19 were included. Laboratory data and real-time reverse transcriptase-polymerase chain reaction [rRT-PCR] for SARS-CoV-2 were obtained from medical records and correlated with those who developed VTE. Results In this study, 1024 patients were identified with confirmed COVID-19, of which 58 patients [5.7%] had VTE. In the bivariate analysis, VTE was associated with chronic kidney disease, hematological disorder, cancer, and high D-dimer>0.50 mg/l. The analysis of the data showed that the number of patients diagnosed with cancer was significantly higher in the VTE group [8 patients, 13.8%] than the non-VTE group [47 patients, 4.9%; p=0.003]. Patients with cancer were 2 times more likely to have VTE [adjusted odds ratio [1]=2.614; 95% CI=[1.048 – 6.519]; p=0.039]. The sensitivity analyses showed that individuals with high D-dimer>0.50 mg/l were more likely to have VTE.Conclusion VTE is more prevalent among individuals with chronic conditions, including cancer. Healthcare professionals should closely monitor individuals with high risk of developing VTE, including those with COVID-19 and chronic conditions, to prevent unwanted complications.
Background Coagulation disorders are frequently encountered among coronavirus disease 2019 [COVID-19]-infected patients, especially among those with more severe symptoms. This study aims to determine the incidence and risk factors of venous thromboembolism [VTE] in COVID-19 patients. Methods The retrospective observational Cohort study was conducted from March to July 2020. All adult patients [> 18 years old] with laboratory-confirmed COVID-19 were included. Laboratory data and real-time reverse transcriptase-polymerase chain reaction [rRT-PCR] for SARS-CoV-2 were obtained from medical records and correlated with those who developed VTE. Results In this study, 1024 patients were identified with confirmed COVID-19, of which 58 patients [5.7%] had VTE. In the bivariate analysis, VTE was associated with chronic kidney disease, hematological disorder, cancer, and high D-dimer > 0.50 mg/l. The analysis of the data showed that the number of patients diagnosed with cancer was significantly higher in the VTE group [8 patients, 13.8%] than the non-VTE group [47 patients, 4.9%; p = 0.003]. Patients with cancer were 2 times more likely to have VTE [adjusted odds ratio [1] = 2.614; 95% CI=[1.048–6.519]; p = 0.039]. The sensitivity analyses showed that individuals with high D-dimer > 0.50 mg/l were more likely to have VTE. Conclusion VTE is more prevalent among individuals with chronic conditions, including cancer. Healthcare professionals should closely monitor individuals with high risk of developing VTE, including those with COVID-19 and chronic conditions, to prevent unwanted complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.